Biopharmaceutics: 11. Disintegration of Dosage forms in Vitro and in Vivo. Part I

Proctor B. S. : Pharm. J. 21: 562, 1862.

Toplis W. G. : Am. J. Pharm. 87: 518, 1915.

Wruble M. S. : Am. J. Pharm. 102: 318, 1930.

Losinski E. , and Diver G. R. : A Direct Method for Studying Efficiency of ‘Enteric’ Tablets, J. Am. Pharm. Assoc. 22: 143–145, 1933.

Pharmacopoeia Helvetica V, 1934.

Wruble M. S. : Enteric Coatings I. A Laboratory Method for the Study and Control of Enteric Coatings, J. Am. Pharm. Assoc. 24: 570–574, 1935.

Bukey F. C. , and Bliven C. W. : Errors in Reported Studies of Enteric Coatings, J. Am. Pharm. Assoc. 25: 119–122, 1936.

Crane A. W. , and Wruble M. S. : Enteric Coatings; Clinical Investigation, Am. J. Roentgenol. Radium Therapy 39: 450, 1938.

Berry F. R. : The Preparation of Compressed Tablets I. The Measurement of the Rate of Disintegration of Compressed Tablets, Quart. J. Pharm. Pharmacol 12: 501–510, 1939.

Oser B. L. , Melnick D. , and Hochberg M. : Physiological Availability of the Vitamins. Study of Methods for Determining Availability in Pharmaceutical Products. Ind. Eng. Chem. Anal. Ed. 17: 401–411, 1945.

Selye F. L. : Absorption of Enteric-Coated Ammonium Chloride, Can. Med. Assoc. J. 55: 445–447, 1946.

Boger W. P. , and Beatty J. O. : Procaine Penicillin Administered Orally: Comparison With Sodium Penicillin, J. Invest. Dermatol. 15: 373–379, 1950.

Higuchi T. , Rao A. N. , Busse L. W. , and Swintosky J. V. : The Physics of Tablet Compression II. The Influence of Degree of Compression on Properties of Tablets, J. Am. Pharm. Assoc. Sci. Ed. 42: 194–200, 1953.

Wright S. S. , Purcell E. R. , Kass E. H. , and Finland M. : Penicillin G and Benzethacil by Mouth: Comparison of Penicillin Levels in Plasma of Normal Men After Single Oral Doses, J. Lab. Clin. Med. 42: 417–429, 1953.

Schulert A. R. , and Weiner M. : The Physiological Disposition of Phenylindanedione in Man, J. Pharmacol. Exptl. Therap. 110: 451–457, 1954.

Chapman D. G. , Crisafio R. , and Campbell J. A. : The Relationship between in vitro Disintegration Time of Sugar Coated Tablets and Physiological Availability of Riboflavin, J. Am. Pharm. Assoc. Sci. Ed. 43: 297–304, 1954.

Chapman D. G. , Crisafio R. , and Campbell J. A. : The Relation Between in vitro Disintegration Time of Sugar-Coated Tablets and Physiological Availability of Sodium p-Aminosalicylate, J. Am. Pharm. Assoc. Sci. Ed. 45: 374–378, 1956.

Endicott C. J. , and Kirchmeyer F. J. : Relationship Between in vitro Tablet Disintegration and Physiological Availability, Drug Std. 24: 193–199, 1956.

Feinblatt T. M. , and Ferguson E. A. : Timed Disintegration Capsules. An in vivo Roentgenographic Study, New Engl. J. Med. 254: 940, 1956.

Wagner J. G. : The Coating of Tablets, Pills and Capsules, in Remington's Practice of Pharmacy, 11th Ed., Martin E. W. , and Cook E. F. , Eds., The Mack Publishing Company, Easton, Pa, 1956, pp. 400–419.

Cooper B. F. , and Brecht E. A. : Surfactants in Tablets to Improve Disintegration J. Am. Pharm. Assoc. Sci. Ed. 46: 520–524, 1957.

Tarnowski C. E. : The Absorption of Shellac-Coated PAS Granules with Special Reference to the Age of the Preparations, Acta Tuberc. Scand. 34: 76–82, 1957.

Juncher H. , and Raaschou F. : The Solubility of Oral Preparations of Penicillin V, Antibiotic Med. Clin. Therapy 4: 497–507, 1957.

Chapman D. G. , Chatten L. G. , and Campbell J. A. : Physiological Availability of Drugs in Tablets, Can. Med. Assoc. J. 76: 102–105, 1957.

Wagner J. G. , Veldkamp W. , and Long S. : Correlation of in vivo with in vitro Disintegration Times of Enteric Coated Tablets: J. Am. Pharm. Assoc. Sci. Ed. 47: 681–685, 1958.

Gruber C. M. Jr. , Ridolfo A. S. , and Tosick W. A. : An Enteric Compression Coating II. In vivo Studies with Barium Sulfate-Potassium Iodide and Barium Sulfate Tablets, J. Am. Pharm. Assoc. Sci. Ed. 47: 862–866, 1958.

Souder J. C. , and Ellenbogen W. C. : Laboratory Control of Dextro Amphetamine Sulfate Sustained Release Capsules, Drug Std. 26: 77–83, 1958.

Wagner J. G. , Brignall T. W. , and Long S. : Enteric Coatings II. Starch (and Amylose) Acetate Phthalates, J. Am. Pharm. Assoc. Sci. Ed. 48: 244–249, 1959.

Morrison A. B. , Chapman D. G. , and Campbell J. A. : Further Studies on the Relation Between in vitro Disintegration Time of Tablets and the Urinary Excretion Rates of Riboflavin, J. Am. Pharm. Assoc. Sci. Ed. 48: 634–637, 1959.

Nogami H. , Hasegawa J. , and Nakai Y. : Studies on Powdered Preparations II. Studies on Tablet Disintegration of Calcium Carbonate by Thermal Analysis, Chem. Pharm. Bull. (Tokyo) 7: 331–337, 1959; ibid. III. Studies on Disintegration of Basic Magnesium Carbonate Tablet, ibid. 7: 337–342, 1959.

Mahoney T. : “The Merchants of Life,” Harper & Brothers Publishers, New York, 1959, p. 133.

Strickland W. A. , Higuchi T. , and Busse L. W. : The Physics of Tablet Compression X. Mechanism of Action and Evaluation of Tablet Lubricants, J. Am. Pharm. Assoc. Sci. Ed. 49: 35–40, 1960.

Forlano A. J. , and Chavkin L. : The Effect of Granule Size Upon Disintegration Time and Capping in Compressed Tablets, J. Am. Pharm. Assoc. Sci. Ed. 49: 67–69, 1960.

Wagner J. G. , and Long S. : Enteric Coating III. An Improved Enteric Coating and Its in vitro Evaluation, J. Am. Pharm. Assoc. Sci. Ed. 49: 121–127, 1960.

Wagner J. G. , Veldkamp W. , and Long S. : Enteric Coating IV. In vivo Testing of Granules and Tablets Coated with Styrene-Maleic Acid Copolymer, J. Am. Pharm. Assoc. Sci. Ed. 49: 128–132, 1960.

Wagner J. G. , Ryan G. W. , Kubiak E. , and Long S. : Enteric Coatings V. pH Dependence and Stability, J. Am. Pharm. Assoc. Sci. Ed. 49: 133–139, 1960.

Wagner J. G. : A Note on the Correlation of in vivo with in vitro Disintegration Times of Enteric Coated Tablets, J. Am. Pharm. Assoc. Sci. Ed. 49: 179, 1960.

Morrison A. B. , and Campbell J. A. : The Relationship Between Physiological Availability of Salicylates and Riboflavin and in vitro Disintegration Time of Enteric Coated Tablets, J. Am. Pharm. Assoc. Sci. Ed. 49: 473–478, 1960.

Swintosky J. V. , and Blythe R. H. : The Excretion of Free Salicylate from an Enteric Coated Tablet and a Compressed Tablet, Drug Std. 58: 5–8, 1960.

Nakai Y. , and Kubo Y. : Studies on Powdered Preparations IV. Studies on Disintegration of Magnesium Oxide Granules and Tablets by Thermal Analysis, Chem. Pharm. Bull. (Tokyo) 8: 634–640, 1960.

Nakai Y. : Studies on Powdered Preparations V. Studies on Particle Size Determination and Tablet Disintegration of Acetylsalicylic Acid by Thermal Analysis, Chem. Pharm. Bull. (Tokyo) 8: 641–646, 1960.

Levy G. , and Knox F. G. : The Biological Activity of Orally Administered Desiccated Thyroid, Am. J. Pharm. 133: 255–256, 1961.

Engel L. : “Medicine Makers of Kalamazoo,” McGraw-Hill Book Company, Inc., New York, 1961, pp. 22–27.

Wagner J. G. : Biopharmaceutics: Absorption Aspects, J. Pharm. Sci. 50: 359–387, 1961.

Wagner J. G. : The Coating of Tablets, Pills and Capsules, in Remington's Practice of Pharmacy, 12th ed., Martin E. W. , and Cook E. F. , eds., The Mack Publishing Company, Easton, Pa., 1961, pp. 476–494.

Morrison A. B. , Perusse C. B. , and Campbell J. A. : Relationship Between in vitro Disintegration Time and in vivo Release of Vitamins from A Triple-Dose Spaced-Release Preparation, J. Pharm. Sci. 51: 623–626, 1962.

Weiss A. , Pittman E. R. , and Graham E. C. : Aspirin and Gastric Bleeding, Am. J. Med. 31: 266–277, 1961.

Kaplan L. L. , and Kish J. A. : Gasket Insert Modification of U.S.P. Tablet Disintegration Apparatus, J. Pharm. Sci. 706, 1962

Nelson E. : Physiochemical and Pharmaceutic Properties of Drugs That Influence Results of Clinical Trials, Clin. Pharmacol. Therap. 3: 673–681, 1962.

Schroeter L. C. , Tingstad J. E. , Knoechel E. L. , and Wagner J. G. : The Specificity of the Relationship Between Rate of Dissolution and Disintegration Time of Compressed Tablets, J. Pharm. Sci. 51: 865–874, 1962.

Ida T. , Takahashi S. , Noda K. , Kishi S. , Nakagami S. , and Utsumi I. : Protective Coatings XVI. Disintegration of Protective-Coated Tablets as Determined by Urinary Excretion in Humans, J. Pharm. Sci. 52: 472–474, 1963.

Levy G. , Antkowiak J. M. , Procknal J. A. , and White D. C. : Effect of Certain Tablet Formulation Factors on Dissolution Rate of the Active Ingredient II. Granule Size, Starch Concentration, and Compression Pressure, J. Pharm. Sci. 52: 1047–1051, 1963.

Macek T. J. : Influence of Product Formulation on Therapeutic Activity, Minnesota Pharmacist 18: 17–18, 22, 27, 30, 1963.

Morrison A. B. , and Campbell J. A. : Physiological Availability of Drugs in Oral Dosage Forms, Indian J. Pharm. 25: 209–214, 1963.

Nogami H. , Fukuzawa H. , and Nakai Y. : Studies on Tablet Disintegration I. The Effect of Penetrating Rate on Tablet Disintegration, Chem. Pharm. Bull. (Tokyo) 11: 1389–1398, 1963.

Hecht G. , and Huyck C. L. : Two Disintegrating Agents versus Cornstarch for Compressed Tablets, J. Pharm. Sci. 23: 112–114, 1964.

Middleton E. J. , Davies J. M. , and Morrison A. B. : Relationship Between Rate of Dissolution, Disintegration Time, and Physiological Availability of Riboflavin in Sugar-Coated Tablets, J. Pharm. Sci. 53: 1378–1380, 1964.

Wagner J. G. : Biopharmaceutics: Gastrointestinal Absorption Aspects, Antibiotica and Chemotherapia, Advances 12: 53–84, 1964.

Corbas H. F. : Enteric Coated Thyroid as a Cause of Relapse in Myxedema, Calif. Med. 100: 364–365, 1964.

Levy G. , and Hollister L. E. : Failure of the U.S.P. Disintegration Test to Assess Physiological Availability of Enteric Coated Tablets, N. Y. J. Med. 64: 3002–3005, 1964.

Brudney N. , Stewart D. J. , and Eustice B. T. : Rates of Dissolution of Tolbutamide Tablets, Cam. Med. Assoc. J. 90: 980–981, 1964.

Lachman L. : The in vivo Effectiveness of Enteric-Film Coatings Applied to Hydrochlorothiazide-Potassium Chloride Tablets by a Programmed Automatic Coating Process, Current Therap. Res. 6: 491–504, 1964.

Morrison A. B. , and Campbell J. A. : Tablet Disintegration and Physiological Availability of Drugs, J. Pharm. Sci. 54: 1–8, 1965.

Bergman L. A. , and Bandelin F. J. : Effects of Concentration, Aging and Temperature on Tablet Disintegrants in a Soluble Direct-Compression System, J. Pharm. Sci. 54: 445–447, 1965.

Steinberg W. H. , Frey G. H. , Masci J. N. , and Hutchins H. H. : Method for Determining in vivo Tablet Disintegration, J. Pharm. Sci. 54: 747–752, 1965.

Leonards J. L. , and Levy G. : Absorption and Metabolism of Aspirin Administered in Enteric Coated Tablets, J. Am. Med. Assoc. 193: 99–104, 1965.

Strivastava L. K. , and Maney P. V. : Development and Testing of Enteric Coatings, Mfg. Chemist 36: 55–58, 1965.

Naito S. I. , and Hirai M. : Studies in Absorption and Excretion of Drugs XV. Inactive Isopropylantipyrine Tablets, Jap. J. Pharm. Chem. 36: 163–167, 1965.

Clark R. L. , and Lasagna L. : How Reliable are Enteric-Coated Aspirin Preparations?, Clin. Pharmacol. Therap. 6: 568–574, 1965.

Lu F. C. , Rice W. B. , and Mainville C. W. : A Comparative Study of Some Brands of Tolbutamide Available in Canada Part II. Pharmaceutical Aspects, Can. Med. Assoc. J. 52: 1166–1169, 1965.

Feinstein W. , and Bartilucci A. J. : Comparative Study of Disintegrating Agents, J. Pharm. Sci. 55: 332–334, 1966

Ingram J. T. , and Lowenthal W. : Mechanism of Action of Starch as a Tablet Disintegrant I. Factors That Affect the Swelling of Starch Grains at 37°, J. Pharm. Sci. 55: 614–617, 1966.

Patel N. R. , and Hoppenon R. E. : Mechanism of Action of Starch as a Disintegrating Agent in Aspirin Tablets, J. Pharm. Sci. 55: 1065–1068, 1966.

Merenda S. J. , and Green D. M. : X-Ray Evaluation of Tablet Disintegration and Gastric Passage, Pharmacologist 8: 180, 1966, No. 2.

Tillis H. H. : The Microspherule Concept of Enteric Coated Salicylates, J. Med. Soc. New Jersey 63: 416–417, 1966.

Rasmussen S. : Intestinal Absorption of Quinine from Enteric Coated Tablets, Acta Pharmacol. Toxicol. 24: 331–345, 1966.

Nogami H. , Nagai T. , and Uchida H. : Studies on Powdered Preparations XIV. Wetting of Powder Bed and Disintegration Time of Tablet, Chem. Pharm. Bull. (Tokyo) 14: 152–158, 1966.

Knoechel E. L. , Sperry C. C. , and Lintner C. J. : Instrumented Rotary Tablet Machines II. Evaluation and Typical Applications in Pharmaceutical Research, Development, and Production Studies, J. Pharm. Sci. 56: 116–130, 1967.

Schroeter L. C. : Dissolution Rate versus Disintegration Time as an Indication of in vivo Drug Availability, Ann. Pharm. Congr. Industrial Panel, N.Y., St. John's University, April 25, 1967, p. 17.

Nogami H. , Hasegawa J. , and Mujamoto M. : Studies on Powdered Preparations XX. Disintegration of the Aspirin Tablets Containing Starches as Disintegration Agents, Chem. Pharm. Bull. (Tokyo) 15: 279–289, 1967.

Ingram J. T. , and Lowenthal W. : Mechanism of Action of Starch as a Tablet Disintegrant II. Effect of Pepsin and Surfactants on Swelling of Starch Grains at 37°, J. Pharm. Sci. 57: 187–188, 1968.

Marks A. M. , and Sciarra J. J. : Effect of Size on Other Physical Properties of Granules and Their Corresponding Tablets, J. Pharm. Sci. 57: 497–504, 1968.

Jouhan A. J. , Garnett E. S. , and Wallington J. S. : Postassium Absorption—A Comparison of in vitro and in vivo Studies, J. Pharm. Sci. 57: 617–620, 1968.

Jacob J. T. , and Plein E. M. : Factors Affecting Dissolution Rates of Medicaments from Tablets II. Effect of Binder Concentration, Tablet Hardness, and Storage Conditions on the Dissolution Rates of Phenobarbital from Tablets, J. Pharm. Sci. 57: 802–805, 1968.

Commons K. C. , Bergen A. , and Walker G. C. : Influence of Starch Concentration on the Disintegration Time of Tolbutamide Tablets, J. Pharm. Sci. 57: 1253–1255, 1968.

Varley A. B. : The Generic Inequivalence of Drugs, J. Am. Med Assoc. 206: 1745–1748, 1968.